AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0150
+0.0002 (1.35%)
May 1, 2024, 10:23 AM EDT - Market open
AXIM Biotechnologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 4 | 4 | 5 | 57 | 48 | 23 | 43 | 493 | 363 | 11 | 330 | Upgrade
|
| Market Cap Growth | - | -5.61% | -91.95% | 19.21% | 111.31% | -47.37% | -91.29% | 35.78% | 3166.08% | -96.63% | 0% | Upgrade
|
| Enterprise Value | 10 | 10 | 10 | 63 | 54 | 28 | 47 | 497 | 364 | 12 | 330 | Upgrade
|
| PE Ratio | -0.60 | -0.54 | -0.77 | -3.45 | -7.10 | -3.34 | -6.36 | -118.27 | -62.49 | -1.10 | -566.09 | Upgrade
|
| PS Ratio | 105.03 | 109.47 | 516.45 | 942.06 | - | 28.28 | 219.63 | 10362.75 | 7715.23 | 226.22 | - | Upgrade
|
| PB Ratio | -0.60 | -0.57 | -0.95 | -24.36 | 30.51 | -3.34 | -7.06 | -78.45 | -153.09 | -6.56 | -568.26 | Upgrade
|
| P/FCF Ratio | -4.43 | -4.20 | -2.23 | -22.45 | -14.42 | -4.50 | -8.87 | -159.96 | -280.55 | -7.14 | -973.45 | Upgrade
|
| P/OCF Ratio | -4.43 | -4.20 | -2.24 | -22.90 | -14.86 | -4.50 | -8.87 | -159.96 | -280.55 | -7.22 | -973.45 | Upgrade
|
| EV/Sales Ratio | 243.38 | 248.70 | 1149.40 | 1045.70 | - | 35.28 | 240.40 | 10454.06 | 7737.74 | 253.00 | - | Upgrade
|
| EV/EBITDA Ratio | -4.33 | -4.23 | -2.41 | -10.77 | -11.13 | -4.34 | -9.36 | -158.18 | -96.94 | -1.24 | -653.29 | Upgrade
|
| EV/EBIT Ratio | -3.66 | -3.57 | -2.19 | -7.92 | -11.10 | -4.34 | -9.34 | -158.01 | -96.86 | -1.24 | - | Upgrade
|
| EV/FCF Ratio | -9.77 | -9.54 | -4.97 | -24.92 | -16.19 | -5.62 | -9.71 | -161.37 | -281.37 | -7.99 | -974.60 | Upgrade
|
| Debt / Equity Ratio | -0.72 | -0.72 | -1.17 | -2.87 | 4.03 | -0.90 | -0.96 | -1.02 | -0.75 | -0.86 | -1.81 | Upgrade
|
| Debt / EBITDA Ratio | -2.43 | -2.43 | -1.34 | -1.14 | -1.31 | -0.94 | -1.17 | -2.04 | -0.47 | -0.14 | -2.08 | Upgrade
|
| Debt / FCF Ratio | -5.49 | -5.49 | -2.76 | -2.65 | -1.90 | -1.22 | -1.21 | -2.08 | -1.37 | -0.93 | -3.10 | Upgrade
|
| Quick Ratio | 0.03 | 0.03 | 0.01 | 0.18 | 0.31 | 0.32 | 0.59 | 0.27 | 0.40 | 0.05 | 0.50 | Upgrade
|
| Current Ratio | 0.03 | 0.03 | 0.03 | 0.25 | 0.48 | 0.48 | 0.61 | 0.27 | 0.46 | 0.46 | 0.56 | Upgrade
|
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.01 | 0 | 0.47 | 0.09 | 0.02 | 0.03 | 0.04 | 0 | Upgrade
|
| Interest Coverage | -3.69 | -2.28 | -2.48 | -16.44 | -15.43 | -20.08 | -3.19 | -3.09 | -12.47 | -232.52 | -15.55 | Upgrade
|
| Return on Equity (ROE) | 131.73% | 105.60% | 123.45% | 706.45% | -429.85% | 100.16% | 111.06% | 66.33% | 244.98% | 595.37% | 100.38% | Upgrade
|
| Return on Assets (ROA) | -242.49% | -194.40% | -141.43% | -310.29% | -59.49% | -400.23% | -323.30% | -190.14% | -400.91% | -799.99% | -78.94% | Upgrade
|
| Return on Capital (ROIC) | 139.37% | 139.37% | -554.34% | -182.27% | -62.84% | 990.80% | 2352.39% | -2689.92% | 627.53% | 4098.48% | -107.77% | Upgrade
|
| Earnings Yield | -240.73% | -186.30% | -129.97% | -29.00% | -14.09% | -29.95% | -15.72% | -0.85% | -1.60% | -90.79% | -0.18% | Upgrade
|
| FCF Yield | -24.67% | -23.82% | -44.79% | -4.45% | -6.93% | -22.20% | -11.28% | -0.63% | -0.36% | -14.00% | -0.10% | Upgrade
|
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.30% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35.39% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Buyback Yield / Dilution | -24.79% | -37.60% | -25.79% | -19.16% | -78.19% | -8.14% | -7.48% | -27.71% | -12.62% | -12.29% | - | Upgrade
|
| Total Shareholder Return | -24.79% | -37.60% | -25.79% | -19.16% | -78.19% | -8.14% | -7.48% | -27.41% | -12.62% | -12.29% | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.